Edges in Network
Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | CD2 |
Upstream (Parents) |
---|
(<<) CD3D → CD2 |
(<<) TRBC1 → CD2 |
Downstream (Children) |
---|
CD2 → AIM2 (>>) |
CD2 → CLDN17 (>>) |
CD2 → PRF1 (>>) |
CD2 → XCL2///XCL1 (>>) |
CD2 → TRAT1 (>>) |
CD2 → CXCL9 (>>) |
CD2 → CD1E (>>) |
CD2 → GPR171 (>>) |
CD2 → CR2 (>>) |
CD2 → TRD@///TRA@ (>>) |
CD2 → LAMP3 (>>) |
CD2 → NRCAM (>>) |
CD2 → TRAJ17///TRAV20///TRD@///TRA@ (>>) |
CD2 → CRTAM (>>) |
CD2 → HLA-DOB (>>) |
CD2 → BIN2 (>>) |
CD2 → SLAMF7 (>>) |
CD2 → TRD@ (>>) |
CD2 → CD3D (>>) |
CD2 → CD3G (>>) |
CD2 → TRBC1 (>>) |
CD2 → CXCR3 (>>) |
CD2 → CD8A (>>) |
CD2 → STK17B (>>) |
CD2 → CCR5 (>>) |
CD2 → C1orf14 (>>) |
CD2 → CD1B (>>) |
CD2 → CXCR6 (>>) |
CD2 → IL18RAP (>>) |
CD2 → CD27 (>>) |
CD2 → KLRK1 (>>) |
CD2 → KLRB1 (>>) |
CD2 → CD79A (>>) |
CD2 → PLA2G7 (>>) |
CD2 → SEPT6 (>>) |
CD2 → CYTIP (>>) |
CD2 → DOK2 (>>) |
CD2 → SP140 (>>) |
CD2 → ARAP2 (>>) |
CD2 → RUNX3 (>>) |
CD2 → CCR7 (>>) |
CD2 → CCL11 (>>) |
CD2 → SELL (>>) |